Title : How could pharmacogenomics help improve patient survival?

Pub. Date : 2007 Aug

PMID : 17686445






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Impressive responses are observed in patients with epidermal growth factor receptor (EGFR) tyrosine kinase mutations following treatment with gefitinib and erlotinib; and methylation of the mitotic checkpoint gene 14-3-3sigma in circulating tumour serum DNA predicts response to cisplatin/gemcitabine therapy. Cisplatin epidermal growth factor receptor Homo sapiens